Novartis announces portfolio transformation, focusing company on leading businesses

Discussion in 'Novartis' started by Anonymous, Apr 22, 2014 at 1:37 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    http://www.nasdaq.com/press-release/novartis-announces-portfolio-transformation-focusing-company-on-leading-businesses-with-innovation-20140422-00014

    Acquires GSK oncology products, strengthening Novartis' leading Oncology business with novel therapies and becomes GSK's preferred commercialization partner for its oncology pipeline

    Combines Novartis OTC with GSK's consumer business in a joint venture, creating a world-leading consumer healthcare business and maintaining Novartis' presence in in this sector

    Divests Vaccines business (excluding flu) to GSK, creating a global leader in vaccines

    In a separate transaction, divests Novartis Animal Health to Lilly

    ...

    "The transactions mark a transformational moment for Novartis. They focus the company on leading businesses with innovation power and global scale. They also improve our financial strength, and are expected to add to our growth rates and margins immediately," said Joseph Jimenez, CEO of Novartis. "We have also created a world-leading consumer healthcare business in our joint venture with GSK. We believe the divestment of our smaller Vaccines and Animal Health Divisions will enable us to realize immediate value from these businesses for our shareholders, and those divisions will benefit from being part of large, global businesses that are also leaders in their segments. Patients will benefit from even higher levels of innovation that this focus may afford. Looking ahead, this positions Novartis well for future healthcare industry dynamics."
     

  2. Anonymous

    Anonymous Guest

    Re: Novartis announces portfolio transformation, focusing company on leading business

    I would love to work for Lilly.